Dhanasiri S. Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells. Bone Marrow Transplant 2020;55:987-988.
PMID: 31754250